Native T1 and Extracellular Volume in Transthyretin Amyloidosis | Zendy

Ana MartinezNaharro | Zendy; Tushar Kotecha | Zendy; Karl Norrington | Zendy; Michele Boldrini | Zendy; Tamer Rezk | Zendy; Candida Cristina Quarta | Zendy; Thomas A. Treibel | Zendy; Carol Whelan | Zendy; Daniel Knight | Zendy; Peter Kellman | Zendy; Frederick L. Ruberg | Zendy; Julian D. Gillmore | Zendy; James Moon | Zendy; Philip N. Hawkins | Zendy; Marianna Fontana | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Native T1 and Extracellular Volume in Transthyretin Amyloidosis

Author(s) -

Ana MartinezNaharro,

Tushar Kotecha,

Karl Norrington,

Michele Boldrini,

Tamer Rezk,

Candida Cristina Quarta,

Thomas A. Treibel,

Carol Whelan,

Daniel Knight,

Peter Kellman,

Frederick L. Ruberg,

Julian D. Gillmore,

James Moon,

Philip N. Hawkins,

Marianna Fontana

Publication year - 2018

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2018.02.006

Subject(s) - medicine , transthyretin , asymptomatic , amyloidosis , hazard ratio , cardiology , cardiac amyloidosis , cardiomyopathy , scintigraphy , confidence interval , heart failure

This study evaluated the prognostic potential of native myocardial T1 in cardiac transthyretin amyloidosis (ATTR) and compared native T1 with extracellular volume (ECV) in terms of diagnostic accuracy and prognosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research